Cepheid today announced that it has been selected by the U.S. Centers for Disease Control and Prevention (CDC) as one of four ...

Though the global number of recorded monkeypox cases continues to climb—passing 4,100 last week, according to the Centers for Disease Control and Prevention (CDC)—many researchers and epidemiologists ...

A Birmingham company is working with Cepheid to develop a PCR test for monkeypox, a virus that has spread to the U.S., though the CDC classifies the threat as low. Birmingham-based BioGX is ...

The cleared assays included point-of-care and home tests for infectious and chronic diseases and drugs of abuse.

With the monkeypox outbreak continuing its steady spread around the globe, diagnostic test makers have taken it upon themselves to develop and roll out tests for the disease as quickly as possible.

(Reuters) - The World Health Organization said on Wednesday it has listed two additional mpox in-vitro diagnostic tests for emergency use. Xpert Mpox, a real-time PCR test manufactured by Cepheid, was ...

Cepheid, a medical device and biotech company based in Sunnyvale, Calif., plans to lay off 686 workers by June 20, according to notices filed with the state. The company, which makes PCR diagnostic ...